TrialBlood2013

Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation.

James N Kochenderfer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.